Furthermore, the reliance of KRAS on Rac1 in lung cancer development also predicts Rac-GEFs as KRAS effectors, also potentially via a PI3K-dependent mechanism (Murillo et al., 2018). This evidence concerns the gene RAC1 and lung carcinoma.